Data from European Society for Medical Oncology (ESMO) - Curated by Toby Galbraith - Last updated 12 October 2017

Status

live

Latest update

13-Jul-17

Mantle cell lymphoma is a relatively uncommon subtype of lymphoid malignancy and is more often found in males than in females. These updated ESMO guidelines provide treatment recommendations for first-line and relapsed disease including the leukaemic non-nodal subtype. Also covered is a summary of recent phase II/III trials investigating dose-intensified first-line therapy in mantle cell lymphoma and a list of published clinical studies investigating molecular targeted approaches for patients in the relapsed stage.

Read full guideline

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Lymphocytic Leukaemia (CLL)

Refine your knowledge of chronic lymphocytic leukaemia (CLL) with information on pathophysiology, diagnosis, treatment options and more

Visit Chronic Lymphocytic Leukaemia (CLL)

Related Content